OTCMKTS:TCHBF Tecan Group (TCHBF) Stock Price, News & Analysis $277.00 0.00 (0.00%) (As of 11/26/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort Interest About Tecan Group Stock (OTCMKTS:TCHBF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Tecan Group alerts:Sign Up Key Stats Today's Range$277.00▼$277.0050-Day Range$277.00▼$327.5152-Week Range$277.00▼$340.27VolumeN/AAverage Volume114 shsMarket CapitalizationN/AP/E Ratio64.87Dividend Yield0.54%Price TargetN/AConsensus RatingN/A Company OverviewTecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.Read More… 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Tecan Group Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks35th Percentile Overall ScoreTCHBF MarketRank™: Tecan Group scored higher than 35% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Tecan Group. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Tecan Group is 64.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.74.Price to Earnings Ratio vs. SectorThe P/E ratio of Tecan Group is 64.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 102.45. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares ShortedShort Interest Ratio / Days to CoverTecan Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tecan Group has recently decreased by 6.60%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend LeadershipTecan Group is a leading dividend payer. It pays a dividend yield of 4.42%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthTecan Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Tecan Group is 35.13%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Tecan Group's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverTecan Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tecan Group has recently decreased by 6.60%, indicating that investor sentiment is improving significantly. News and Social Media1.0 / 5News SentimentN/A News SentimentTecan Group has a news sentiment score of -0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Tecan Group insiders have not sold or bought any company stock.Percentage Held by Institutions46.80% of the stock of Tecan Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Tecan Group's insider trading history. Receive TCHBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tecan Group and its competitors with MarketBeat's FREE daily newsletter. Email Address TCHBF Stock News HeadlinesTecan price target lowered to CHF 264 from CHF 328 at BerenbergNovember 19, 2024 | markets.businessinsider.comTecan downgraded to Neutral from Buy at UBSNovember 3, 2024 | markets.businessinsider.com“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.November 27, 2024 | Weiss Ratings (Ad)Tecan Group Share Chat (0QLN)November 1, 2024 | lse.co.ukAnalysts Offer Insights on Healthcare Companies: Tecan Group AG (OtherTCHBF) and Argenx Se (ARGX)November 1, 2024 | markets.businessinsider.comTecan price target lowered to CHF 259 from CHF 300 at Morgan StanleyOctober 25, 2024 | markets.businessinsider.comTecan’s Capital Markets Day highlights strategic growth drivers, groundbreaking innovation and product launchesOctober 23, 2024 | uk.finance.yahoo.comTCHBF Tecan Group AGOctober 19, 2024 | seekingalpha.comSee More Headlines TCHBF Stock Analysis - Frequently Asked Questions How have TCHBF shares performed this year? Tecan Group's stock was trading at $381.00 on January 1st, 2024. Since then, TCHBF shares have decreased by 27.3% and is now trading at $277.00. View the best growth stocks for 2024 here. How do I buy shares of Tecan Group? Shares of TCHBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryPersonal Services Current SymbolOTCMKTS:TCHBF CUSIPN/A CIKN/A Webwww.tecan.com Phone(144) 922-8888FaxN/AEmployees3,315Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio64.87 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report This page (OTCMKTS:TCHBF) was last updated on 11/27/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tecan Group AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Tecan Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.